Photo from wikipedia
Among those who study granulomatous diseases, sarcoidosis is of tremendous interest, not only because its cause is unknown, but also because it is still as much an enigma today as… Click to show full abstract
Among those who study granulomatous diseases, sarcoidosis is of tremendous interest, not only because its cause is unknown, but also because it is still as much an enigma today as it was 150 years ago when Jonathan Hutchinson first described the cutaneous form of the disease as “livid papillary psoriasis”. This piece editorializes a comparative effectiveness study of methotrexate versus methylprednisolone in treatment naïve pulmonary sarcoidosis patients for CT-guided clinical responses and drug-related adverse events.
Keywords:
versus methylprednisolone;
methotrexate versus;
methylprednisolone treatment;
comparative effectiveness;
pulmonary sarcoidosis;
treatment pulmonary
Journal Title: Diagnostics
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diagnostics
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!